SELLAS Life Sciences Group, Inc. — Institutional Ownership
Which tracked institutions hold SLS, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
23
Funds holding
$548830174
Total value held
Buying
21 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $222437657 | 15070302 | +2871892 | +23.54% |
| 2 | State Street Corp | $191829196 | 12996558 | +4600202 | +54.79% |
| 3 | Northern Trust Corp | $23910138 | 1619928 | +343944 | +26.96% |
| 4 | Ubs Group Ag | $18490693 | 1252757 | +1252757 | NEW BUY |
| 5 | Morgan Stanley | $18247211 | 1236261 | -100032 | -7.49% |
| 6 | Barclays Plc | $12359774 | 837383 | +804971 | +2483.56% |
| 7 | Bank Of America Corp /De/ | $11630128 | 787949 | +146266 | +22.79% |
| 8 | Goldman Sachs Group Inc | $8635117 | 585035 | +29122 | +5.24% |
| 9 | Bank Of New York Mellon Corp | $7823173 | 530025 | +51659 | +10.80% |
| 10 | Nomura Holdings Inc | $6642000 | 450000 | +13300 | +3.05% |
| 11 | Jefferies Financial Group Inc. | $5912251 | 400559 | +400559 | NEW BUY |
| 12 | Invesco Ltd. | $5540049 | 375342 | +375342 | NEW BUY |
| 13 | Wells Fargo & Company/Mn | $4853368 | 328819 | +103112 | +45.68% |
| 14 | Citigroup Inc | $4820483 | 326591 | +271116 | +488.72% |
| 15 | Franklin Resources Inc | $1758742 | 119156 | +119156 | NEW BUY |
| 16 | Jpmorgan Chase & Co | $1547086 | 100135 | +18311 | +22.38% |
| 17 | Fifth Third Bancorp | $888404 | 60190 | +383 | +0.64% |
| 18 | Prudential Financial Inc | $459184 | 31110 | +2420 | +8.43% |
| 19 | Sei Investments Co | $392336 | 26581 | — | Held |
| 20 | Royal Bank Of Canada | $218000 | 14828 | +10657 | +255.50% |
| 21 | Principal Financial Group Inc | $213002 | 14431 | +2002 | +16.11% |
| 22 | Stifel Financial Corp | $183304 | 12419 | +12419 | NEW BUY |
| 23 | Pnc Financial Services Group, Inc. | $38878 | 2634 | +2345 | +811.42% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.